{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:28:14Z","timestamp":1792477694592,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T00:00:00Z","timestamp":1430265600000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.nbd.2015.01.002","type":"journal-article","created":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T08:14:25Z","timestamp":1422951265000},"page":"46-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"C","title":["Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease"],"prefix":"10.1016","volume":"76","author":[{"given":"Amber L.","family":"Southwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Franciosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika B.","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie A.","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janaki","family":"Veeraraghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Jonason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boguslaw","family":"Felczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weining","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad","family":"Kovalik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Waltl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9030-0976","authenticated-orcid":false,"given":"Mahmoud A.","family":"Pouladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest S.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2255-2116","authenticated-orcid":false,"given":"William J.","family":"Bowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Zauderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2015.01.002_bb0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.nurt.2008.01.008","article-title":"Symptomatic treatment of Huntington disease","volume":"5","author":"Adam","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2015.01.002_bb0010","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000334276.09729.0e","article-title":"Weight loss in Huntington disease increases with higher CAG repeat number","volume":"71","author":"Aziz","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.01.002_bb0015","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddq018","article-title":"Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis","volume":"19","author":"Becanovic","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.01.002_bb0020","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bjorkqvist","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2015.01.002_bb0025","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s11481-012-9409-5","article-title":"Common transcriptional signatures in brain tissue from patients with HIV-associated neurocognitive disorders, Alzheimer's disease, and multiple sclerosis","volume":"7","author":"Borjabad","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.nbd.2015.01.002_bb0030","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4049\/jimmunol.148.2.318","article-title":"Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation","volume":"148","author":"Bougeret","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2015.01.002_bb0035","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0028-3932(85)90080-6","article-title":"Memory disorders associated with Huntington's disease: verbal recall, verbal recognition and procedural memory","volume":"23","author":"Butters","year":"1985","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.nbd.2015.01.002_bb0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1750-1326-6-59","article-title":"Mice lacking caspase-2 are protected from behavioral changes, but not pathology, in the YAC128 model of Huntington disease","volume":"6","author":"Carroll","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2015.01.002_bb0045","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.nbd.2011.03.018","article-title":"Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease","volume":"43","author":"Carroll","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.01.002_bb0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tcb.2009.01.005","article-title":"Huntingtin as an essential integrator of intracellular vesicular trafficking","volume":"19","author":"Caviston","year":"2009","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.nbd.2015.01.002_bb0055","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1091\/mbc.e10-03-0233","article-title":"Huntingtin coordinates the dynein-mediated dynamic positioning of endosomes and lysosomes","volume":"22","author":"Caviston","year":"2011","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.nbd.2015.01.002_bb0060","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.1523\/JNEUROSCI.0388-12.2012","article-title":"R6\/2 Huntington's disease mice develop early and progressive abnormal brain metabolism and seizures","volume":"32","author":"Cepeda-Prado","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.01.002_bb0065","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","article-title":"Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study","volume":"62","author":"Duff","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2015.01.002_bb0070","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s13311-012-0112-2","article-title":"Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease","volume":"9","author":"Ehrlich","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2015.01.002_bb0075","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nrd3556","article-title":"Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development","volume":"10","author":"Ehrnhoefer","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2015.01.002_bb0080","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.4049\/jimmunol.166.7.4341","article-title":"Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis","volume":"166","author":"Elhabazi","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2015.01.002_bb0085","doi-asserted-by":"crossref","first-page":"Pt A:8","DOI":"10.1016\/j.expneurol.2014.02.006","article-title":"Molecular mechanisms linking neuroinflammation and neurodegeneration in MS","volume":"262","author":"Ellwardt","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.01.002_bb0090","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.cell.2014.01.044","article-title":"Neurogenesis in the striatum of the adult human brain","volume":"156","author":"Ernst","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2015.01.002_bb0095","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2011.09.003","article-title":"Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease","volume":"45","author":"Franciosi","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.01.002_bb0100","doi-asserted-by":"crossref","first-page":"33376","DOI":"10.1074\/jbc.271.52.33376","article-title":"Identification of a novel transmembrane semaphorin expressed on lymphocytes","volume":"271","author":"Furuyama","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2015.01.002_bb0105","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.4049\/jimmunol.172.2.1246","article-title":"Semaphorin CD100 from activated T lymphocytes induces process extension collapse in oligodendrocytes and death of immature neural cells","volume":"172","author":"Giraudon","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2015.01.002_bb0110","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.01.002_bb0115","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1126\/science.8091209","article-title":"The basal ganglia and adaptive motor control","volume":"265","author":"Graybiel","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.nbd.2015.01.002_bb0120","article-title":"Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial","volume":"66","author":"Group","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.01.002_bb0125","doi-asserted-by":"crossref","first-page":"11780","DOI":"10.1073\/pnas.93.21.11780","article-title":"Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation","volume":"93","author":"Hall","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2015.01.002_bb0130","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.","volume":"72","author":"HDCRG","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2015.01.002_bb0135","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.01.002_bb0140","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1007\/s00018-012-1019-0","article-title":"Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions","volume":"69","author":"Hota","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.nbd.2015.01.002_bb0145","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage","volume":"16","author":"Kuhn","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.01.002_bb0150","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1074-7613(00)00062-5","article-title":"Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling","volume":"13","author":"Kumanogoh","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.nbd.2015.01.002_bb0155","doi-asserted-by":"crossref","first-page":"8961","DOI":"10.1523\/JNEUROSCI.0989-13.2013","article-title":"The class 4 semaphorin Sema4D promotes the rapid assembly of GABAergic synapses in rodent hippocampus","volume":"33","author":"Kuzirian","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.01.002_bb0160","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00702-011-0607-8","article-title":"Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease","volume":"118","author":"Lassmann","year":"2011","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2015.01.002_bb0165","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1086\/318207","article-title":"Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo","volume":"68","author":"Leavitt","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2015.01.002_bb0170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.expneurol.2013.08.019","article-title":"Neurovascular abnormalities in humans and mice with Huntington's disease","volume":"250","author":"Lin","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.01.002_bb0175","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.20428","article-title":"Plasma testosterone in male patients with Huntington's disease: relations to severity of illness and dementia","volume":"57","author":"Markianos","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.01.002_bb0180","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrn2995","article-title":"Engaging neuroscience to advance translational research in brain barrier biology","volume":"12","author":"Neuwelt","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2015.01.002_bb0185","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.4049\/jimmunol.0903302","article-title":"Roles of Sema4D-plexin-B1 interactions in the central nervous system for pathogenesis of experimental autoimmune encephalomyelitis","volume":"184","author":"Okuno","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2015.01.002_bb0190","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neuron.2006.12.012","article-title":"An RNAi-based approach identifies molecules required for glutamatergic and GABAergic synapse development","volume":"53","author":"Paradis","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.01.002_bb0195","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/hmg\/ddn428","article-title":"Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models","volume":"18","author":"Phan","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.01.002_bb0200","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/brain\/awp006","article-title":"Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin","volume":"132","author":"Pouladi","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.01.002_bb0205","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/00048679109077743","article-title":"The fertility of HD-affected individuals in Tasmania","volume":"25","author":"Pridmore","year":"1991","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.nbd.2015.01.002_bb0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mcn.2013.08.004","article-title":"Sema4D localizes to synapses and regulates GABAergic synapse development as a membrane-bound molecule in the mammalian hippocampus","volume":"57","author":"Raissi","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2015.01.002_bb0215","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2015.01.002_bb0220","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0896-6273(95)90345-3","article-title":"Widespread expression of Huntington's disease gene (IT15) protein product","volume":"14","author":"Sharp","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.01.002_bb0225","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1074-7613(00)00063-7","article-title":"The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T Cell activation in CD100-deficient mice","volume":"13","author":"Shi","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.nbd.2015.01.002_bb0230","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.01.002_bb0235","first-page":"254","article-title":"SEMA4D compromises Blood\u2013Brain Barrier and inhibits remyelination in neurodegenerative disease","volume":"73C","author":"Smith","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.01.002_bb0240","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","article-title":"Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease","volume":"29","author":"Southwell","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.01.002_bb0245","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/hmg\/dds397","article-title":"A fully humanized transgenic mouse model of Huntington disease","volume":"22","author":"Southwell","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.01.002_bb0250","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng1193-259","article-title":"Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues","volume":"5","author":"Strong","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2015.01.002_bb0255","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ni1553","article-title":"Semaphorins and their receptors in immune cell interactions","volume":"9","author":"Suzuki","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.nbd.2015.01.002_bb0260","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0896-6273(02)00750-X","article-title":"Plexin-B1 directly interacts with PDZ-RhoGEF\/LARG to regulate RhoA and growth cone morphology","volume":"35","author":"Swiercz","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.01.002_bb0265","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","article-title":"Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data","volume":"8","author":"Tabrizi","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2015.01.002_bb0280","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/hmg\/ddi147","article-title":"Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease","volume":"14","author":"Van Raamsdonk","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.01.002_bb0270","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1093\/hmg\/ddl072","article-title":"Body weight is modulated by levels of full-length Huntingtin","volume":"15","author":"Van Raamsdonk","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.01.002_bb0275","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.nbd.2007.01.006","article-title":"Testicular degeneration in Huntington disease","volume":"26","author":"Van Raamsdonk","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.01.002_bb0285","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.mcn.2011.12.004","article-title":"Sema4D as an inhibitory regulator in oligodendrocyte development","volume":"49","author":"Yamaguchi","year":"2012","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2015.01.002_bb0290","doi-asserted-by":"crossref","first-page":"e25826","DOI":"10.1371\/journal.pone.0025826","article-title":"Plexin-B1 activates NF-kB and IL-8 to promote a pro-angiogenic response in endothelial cells","volume":"6","author":"Yang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2015.01.002_bb0295","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1073\/pnas.0606344104","article-title":"Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury","volume":"104","author":"Zhu","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2015.01.002_bb0300","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington's disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiol. Rev."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115000145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115000145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T19:08:08Z","timestamp":1691003288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996115000145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":60,"alternative-id":["S0969996115000145"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2015.01.002","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2015.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}